These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1235 related items for PubMed ID: 31666021

  • 1. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A, Jamil M, Rahman MAU, Mustafa T.
    BMC Infect Dis; 2019 Oct 30; 19(1):923. PubMed ID: 31666021
    [Abstract] [Full Text] [Related]

  • 2. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar 30; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    Kawasaki M, Echiverri C, Raymond L, Cadena E, Reside E, Gler MT, Oda T, Ito R, Higashiyama R, Katsuragi K, Liu Y.
    PLoS Med; 2019 Apr 30; 16(4):e1002780. PubMed ID: 30978194
    [Abstract] [Full Text] [Related]

  • 8. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S, Kumar A, Kapoor SK.
    Indian J Tuberc; 2012 Jul 30; 59(3):135-40. PubMed ID: 23362709
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic performance of genoType® MTBDRplus line probe assay in bronchoalveolar lavage for pulmonary tuberculosis diagnosis in sputum scarce and smear-negative patients.
    Idrees F, Irfan M, Jabeen K, Farooqi J, Hasan R.
    Int J Mycobacteriol; 2017 Jul 30; 6(2):122-126. PubMed ID: 28559511
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
    Lancet; 1975 Jan 18; 1(7899):119-24. PubMed ID: 46047
    [Abstract] [Full Text] [Related]

  • 14. Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment.
    McAulay K, Saito K, Warrier T, Walsh KF, Mathurin LD, Royal-Mardi G, Lee MH, Ocheretina O, Pape JW, Fitzgerald DW, Nathan CF.
    mBio; 2018 Nov 20; 9(6):. PubMed ID: 30459198
    [Abstract] [Full Text] [Related]

  • 15. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S.
    East Afr Med J; 1999 Jun 20; 76(6):307-13. PubMed ID: 10750516
    [Abstract] [Full Text] [Related]

  • 16. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
    Al-Shaer MH, Elewa H, Alkabab Y, Nazer LH, Heysell SK.
    BMC Infect Dis; 2018 Aug 08; 18(1):384. PubMed ID: 30089476
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
    Yew WW, Chan CK, Chau CH, Tam CM, Leung CC, Wong PC, Lee J.
    Chest; 2000 Mar 08; 117(3):744-51. PubMed ID: 10713001
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis.
    Kang HK, Jeong BH, Lee H, Park HY, Jeon K, Huh HJ, Ki CS, Lee NY, Koh WJ.
    Medicine (Baltimore); 2016 Aug 08; 95(31):e4540. PubMed ID: 27495111
    [Abstract] [Full Text] [Related]

  • 19. Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial.
    Lee JK, Lee JY, Kim DK, Yoon HI, Jeong I, Heo EY, Park YS, Jo YS, Lee JH, Park SS, Park JS, Kim J, Lee SM, Joh JS, Lee CH, Lee J, Choi SM, Park JH, Lee SH, Cho YJ, Lee YJ, Kim SJ, Kwak N, Hwang YR, Kim H, Ki J, Lim JN, Choi HS, Lee M, Song T, Kim HS, Han J, Ahn H, Hahn S, Yim JJ.
    Lancet Infect Dis; 2019 Jan 08; 19(1):46-55. PubMed ID: 30477961
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 08; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.